SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-008932
Filing Date
2019-05-16
Accepted
2019-05-16 07:26:00
Documents
6
Period of Report
2019-05-16

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k051619_aurismedicalhold.htm 6-K 30202
2 UNDERWRITING AGREEMENT, DATED MAY 13, 2019, BETWEEN AURIS MEDICAL HOLDING LTD. A f6k051619ex1-1_auris.htm EX-1.1 252609
3 FORM OF COMMON WARRANT f6k051619ex4-1_auris.htm EX-4.1 128324
4 FORM OF PRE-FUNDED WARRANT f6k051619ex4-2_auris.htm EX-4.2 127062
5 COMMON WARRANT AGENT AGREEMENT f6k051619ex4-3_auris.htm EX-4.3 210169
6 PRE-FUNDED WARRANT AGENT AGREEMENT f6k051619ex4-4_auris.htm EX-4.4 207167
  Complete submission text file 0001213900-19-008932.txt   956813
Mailing Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000
Business Address BAHNHOFSTRASSE 21 6300 ZUG V8 00000 41 (0)61 201 13 50
Auris Medical Holding Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 19830542
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences